Form D · Biotechnology

EOLO USA, Inc.

Wilmington, DE · CIK 0001961558

Offering snapshot reported Feb 14, 2023 · SEC filing

Reported sold
$1.8M
Offering amount: $3M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 7, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$900K$1.8MFeb 8, 2023: $1,799,999.00Feb 8, 2023Feb 14, 2023: $1,799,999.00Feb 14, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 14, 2023Amendment$1,799,999$0vs Feb 8, 20239SEC filing
Feb 8, 2023Initial$1,799,999No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-472955

Source: Form D, filed Feb 14, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul Elberse Director
Carlos Jose Escande Executive
Maria Pia Garat Director, Executive, Promoter
Roland Haag Director
Gerardo Marchesini Director
Maria Pia Garat Nunez Director, Executive, Promoter
Nicolas Tognalli Tognalli Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1209 Orange Street
Wilmington, DE, 19801